Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cell Therapeutics (CTIC) -- Ignore unavailable to you. Want to Upgrade?

To: Icebrg who wrote (326)	12/6/2004 3:44:32 PM
From: zeta1961	Read Replies (1) \| Respond to of 946

MGI Pharma has bought into Supergen's Dacogen, I didn't put $$ into it but the overview in the first link by the M.D. Anderson doc piqued my interest..I also see 'epigenetics' floating around in my cancer newsletters.. <MDS>..trying to put together data currently available(gosh..need a spread sheet<g>) I realize this is a small indication..sorry in advance if this feels cluttery.. ir.supergen.com Overview of epigenetics, MDS, critical differences(according to author) between AzaC and Dacogen(by M.D. Anderson doc) discussion of dacogen's results earlier in the year.. Message 19977309 Message 20829517 PHRM's AzaC label Message 20829943 Telk's ASH '04 results sabcs.org midway down the page..12Noon-3pm various discussions on epigenetics and breast cancer Ok..did the digging..now the brains here have to, if so inclined take over<g> Peter..I don't follow this closely enough for enrollment..I have a concern with most cancer trials accruing patients?..esp. with NHL?..several combo's to choose from?? don't know.. Zeta